Establishing industrial production of components that enable expanding accessibility of pet imaging to cancer patient population. - CRP technical assistance is intended to accomplish the following for…

Ended Project Grant Awarded Last action

Award ID
SB1CA192499
Recipient
Awarding agency
Obligated
$406,157

Award facts

Assistance listing
93.394 Cancer Detection and Diagnosis Research
Completion date
Originally
Place of performance
California, USA

Award details come from USAspending.gov.

Description

Establishing industrial production of components that enable expanding accessibility of pet imaging to cancer patient population. - CRP technical assistance is intended to accomplish the following for tracer-QC product under development. IT will establish industrial production methods (specifically high-precision injection molding) necessary to ensure consistent and controlled scale-up manufacturing of tracer-QC analysis plates that are currently manufactured by non-salable, variable and costly machining process. CRP problem. Trace-ability is focusing a lot of current effort on scaling up tracer-QC kit production to the levels that can supply the entire pet industry with high-quality kits. However, there is one aspect where the current manufacturing technology is not scalable and carries quality risks. IT needs to be replaced by a completely new technology in order to support the pet industry. Specifically, IT is the manufacturing of the core tracer-QC analysis plate in which all QC assessments take place. Current plates are made by cutting standard 384-well plates. Such process is not scalable. IT has inherent plate-to-plate variability and a high risk of debris contaminating the wells required for precise optical analysis. CRP solution. Trace-ability has developed a proposal together with agilent technologies, INC. To manufacture analysis plates by injection molding. This project is designed to establish scalable production of analysis plates and RE- validate all existing tracer-QC assays in these plates. Specific aim 1: scalable injection molding process for manufacturing high-quality analysis plates. The "high-quality" acceptance criteria are (a) well absorbance

Transactions

Action Obligated Date
Amendment $0
Amendment $93,843
Amendment $156,157
Original award $156,157

Quick answers

Who received award SB1CA192499?

SB1CA192499 was awarded to Trace-Ability Inc. by National Cancer Institute (National Institutes of Health) on May 1, 2023.

How much is award SB1CA192499 worth?

$406,157 has been obligated on SB1CA192499.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award